IL1B and VEXAS syndrome: Although SchS, characterized by aberrant inflammasome activation with excessive interleukin‐1β (IL‐1β) production and typically IgM clonal gammopathy, is a well‐recognized entity within this group, VEXAS syndrome, has not yet been classified as such.5